TORONTO, March 25, 2022 /CNW/ - SQI Diagnostics Inc.
(TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health
that develops and manufactures respiratory health and precision
medicine tests, announced today that Company CEO Andrew Morris has been invited to present at the
2022 Virtual Growth Conference, presented by Maxim Group LLC and
hosted by M-Vest, on March 28th -
30th from 9:00 a.m. - 5:00
p.m. EDT.
Sign up here to access the presentation
During this virtual conference, investors will hear from
executives from a wide range of sectors including Biotech, Clean
Energy, Electric Vehicles, Financial Services, Fintech & REITS,
Gaming & Entertainment, Healthcare, Healthcare IT,
Infrastructure, Shipping and Technology/ Media/Telecom. The
conference will feature company presentations, fireside chats,
roundtable discussions, and live Q&A with CEOs moderated by
Maxim Research Analysts.
This conference will be live on M-Vest. To attend, just sign up
to become an M-Vest member.
Click Here to Reserve your seat
About SQI Diagnostics
SQI Diagnostics is a leader in the science of lung health. The
Company develops and manufactures respiratory health and precision
medicine tests that run on SQI's fully automated systems. The
Company's tests simplify and improve COVID19 antibody monitoring,
Rapid Acute Lung Injury testing, donor organ transplant
informatics, and immunological protein and antibody testing. SQI
Diagnostics is driven to create and market life-saving testing
technologies that help more people in more places live longer,
healthier lives. For more information, please
visit www.sqidiagnostics.com.
FORWARD-LOOKING
INFORMATION
This press release contains certain words and statements,
which may constitute "forward-looking statements" within the
meaning of applicable securities laws relating to future events or
future performance and reflect the current expectations and
assumptions of the Company regarding its growth, results of
operations, performance, business prospects and opportunities.
These statements generally can be identified by use of
forward-looking words such as "may", "would", "could", "will",
"should", "expect", "plan", "estimate", "anticipate", "intends",
"believe", "potential", or "continue" or the negative thereof or
similar variations. The Company's actual results and performance
discussed herein could differ materially from those expressed or
implied by such statements. Such statements are qualified in their
entirety by the inherent risks and uncertainties surrounding future
expectations. Important factors that could cause actual results to
differ materially from expectations include, among other things,
general economic and market factors, competition, the effect of the
global pandemic and consequent economic disruption, and the factors
detailed in the Company's ongoing filings with the securities
regulatory authorities, available
at www.sedar.com.
Although the forward-looking statements contained herein are
based on what we consider to be reasonable assumptions based on
information currently available to us, there can be no assurance
that actual events, performance or results will be consistent with
these forward-looking statements, and our assumptions may prove to
be incorrect. Readers are cautioned not to place undue reliance on
these forward-looking statements. The Company undertakes no
obligation to publicly update or revise any forward-looking
statements either as a result of new information, future events or
otherwise, except as required by applicable law.
This news release does not constitute an offer to sell or a
solicitation of an offer to sell any of the securities in the
United States. The securities have
not been and will not be registered under the U.S. Securities Act
or any state securities laws and may not be offered or sold
within the United States or to U.S. persons unless
registered under the U.S. Securities Act and applicable state
securities laws or an exemption from such registration is
available.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Contact:
Chief Financial Officer
Morlan Reddock
416.674.9500 ext. 277
mreddock@sqidiagnostics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sqi-diagnostics-inc-to-participate-in-the-2022-virtual-growth-conference-presented-by-maxim-group-llc-and-hosted-by-m-vest-on-march-28th---30th-from-900-am---500-pm-edt-301511049.html
SOURCE SQI Diagnostics Inc.